Recently, the domestically produced new coronavirus vaccine has gradually begun vaccination.
According to media reports, the current annual production capacity of the Beijing Institute of Biological Products inactivated vaccine for the new crown reaches 120 million doses, and the production capacity will be increased in the future, and the annual production capacity is expected to reach more than 1 billion doses.
The production of vaccines requires inoculation of the virus strains into cells for cultivation. Because the new coronavirus has the characteristics of airborne transmission, the production of vaccines requires high safety and needs to be carried out in high-level biosafety workshops.
What does the vaccine production workshop look like?
Let's take a look!
(Reporter Wen Mengxin Source of material: Sinopharm Group China Bio)
Editor in charge: [Liu Xian]